All lobbying filings

TODD STRATEGY GROUP

Lobbying for PFIZER INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Mar 17, 2026

Official filing document

Bills named in this filing 3

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 2214
DRUG Act
S 832
EPIC Act of 2025

Lobbying activity 3

Pharmacy

Issues related to FDA regulation of pharmaceuticals. H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Vaccine Policy, Coverage and Access and the Vaccine Injury Compensation Fund. H.R.2214 - DRUG Act. S.832 - EPIC Act of 2025.

Tariff (miscellaneous tariff bills)

Issues related to tariff and trade policy. International Supply Chain.

Trade (domestic/foreign)

Issues related to tariff and trade policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.